Sign up for a free trial now
  • Login
  • Subscribe
  • Take a FREE Trial
  • About Us
  • Contact us
  • RSS

23 May 2013


The Pharma Letter
  • Home
  • 7 Day Premium Trial
  • Pharmaceuticals
  • Biotechnology
  • Generics
  • Events
  • Companies
  • Drugs
  • Subscribe

Beclomethasone Dipropionate HFA Articles

Teva's QVAR effective in "real life" study

23 March 2009

Dainippon to give drug marketing a lift

27 September 2004

Tokyo pharma stocks - week to July 5

12 July 2004

IVAX confirms 3M product deal

27 October 2003

IVAX expands respiratory franchise in Europe

21 July 2003

IVAX wins F&S strategy award

26 May 2003

IVAX ' QVAR OKed for US pediatric use

20 May 2002

Tokyo pharma stocks - week to April 29

6 May 2002

IVAX expands US asthma products line with 3M's QVAR brand

8 April 2002

3M's QVAR inhaler cleared in USA

19 September 2000

Recent developments in drug delivery - by Mark Greener

19 January 2000

Lilly rapped over claims for Evista

14 January 1999

Showing 1-12 of 12 articles

Go to beginningPrevious
  • 1
NextGo to end
  • Hot Topics
  • Most Read
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures
  • Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
  • Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
  • AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
  • Is failure to adopt business process management putting the pharma industry at risk?
  • Boehringer Ingelheim gets FDA warning letter on cGMP failures
  • Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
  • Ignyta acquires Actagene Oncology and entry into cancer personalized medicine

30 Day Premium Trial


Events

Twitter Right banner

RSS



© 2013 thepharmaletter.com

  • Home
  • RSS
  • About Us
  • Subscribe
  • Terms and Conditions
  • Article Archive
Site powered by WORKSsitebuilder CMS